Amit Kumar - May 31, 2021 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Stock symbol
ANIX
Transactions as of
May 31, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 05:00 PM
Next filing
Jul 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +2M $0.00 2M Jun 1, 2021 Common Stock 2M $4.02 Direct F1, F2
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +500K $0.00 500K Jun 1, 2021 Common Stock 500K $4.02 Direct F1, F3
transaction ANIX Restricted Stock Award Disposed to Issuer $0 -1.5M -100% $0.00* 0 May 31, 2021 Common Stock 1.5M $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable as follows: (i) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $5.00, (ii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $6.00, (iii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $7.00, and (iv) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $8.00.
F3 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.
F4 The vesting requirements were not met and the restricted stock award expired on May 31, 2021.